Uterine fibroids, uterine adenomyosis, uterine prolapse, ovarian cysts, adnexal masses, endometrial atypical hyperplasia, uterine intraepithelial neoplasia
Conditions
Interventions
Experimental group:0.375% Ropivacaine 20ml+ Dexmedetomidine 0.5ug /kg
Control group:0.375% Ropivacaine 20ml
Sponsors
Beijing Miyun District Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: ASA I ~ II class; Age: 18 ~ 65 years old; Gynecological laparoscopic surgery (including unilateral laparoscopic adnexectomy, unilateral ovarian cyst removal, total hysterectomy, hysteromyomectomy, etc.) is planned to be performed under general anesthesia.
Exclusion criteria
Exclusion criteria: Contraindications to drug use (asthma, hepatorenal insufficiency, digestive tract ulcer, sinus bradycardia, etc.) were involved. Morbid obese patients (BMI> 40kg/m2); Patients who used opioids before surgery; Patients with contraindications of lumboquadrate block (block site infection, etc.); Drug addicts; Patients with alcoholism; Vertigo patients; Patients with chronic constipation; Patients with esophageal reflux; Patients with chronic pain; Intellectual disabilities are unable to complete pain scoring or use patient-controlled intravenous analgesia regimens.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total dose of postoperative relief analgesics; | — |
Secondary
| Measure | Time frame |
|---|---|
| The first postoperative analgesia is required ;Postoperative pain intensity at different time points (including resting and exercise NRS score) ; | — |
Countries
China
Contacts
Public ContactMengyao Qi
Beijing Miyun District Hospital
Outcome results
None listed